Chronic Subjective Dizziness Clinical Trial
Official title:
Effect of Jaeumgeonbi-Tang on Chronic Subjective Dizziness: A Randomized, Double-Blind, Parallel-group, Placebo-Controlled Trial
The goal of this study is to assess the safety and efficacy of JGT (Jaeumgeonbi-Tang). A randomized, double-blind, parallel-group, placebo-controlled clinical trial was conducted and changes in symptoms and quality of life of the patients were evaluated.
This study's protocol was designed to assess the efficacy of JGT (Jaeumgeonbi-Tang) for chronic subjective dizziness. - This design of the study is a randomized, double-blind, parallel-group, placebo-controlled design. - Symptoms and quality of life of chronic subjective dizziness patients will be evaluated. - Dizziness severity and quality of life of the patients will be evaluated using DHI (Dizziness Handicap Inventory) (1) before treatment (baseline), (2) after 2 weeks, and (3) after 4 weeks of JGT treatment. - Blood samples of the patients will be gathered before and after JGT treatment for pathophysiological analysis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01669304 -
Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness
|
Phase 1 |